Related Experiment Video
Updated: Jul 10, 2026

Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Midbrain dopamine loss drives parvalbumin interneuron vulnerability through tissue plasminogen activator-linked
Emma Cauzzi1, Serena Ficchì1, Maria Luisa De Paolis2
1Department of Medicine, Surgery and Dentistry, Università Campus Bio-Medico di Roma, 00128 Roma, Italy.
Abstract:
Midbrain dopaminergic degeneration is an early feature of Alzheimer's Disease (AD), dementia with Lewy bodies (DLB), and AD-Parkinson's disease overlap (AD-PD). However, its direct contribution to the failure of hippocampal inhibitory-circuits, a pathological feature shared across these conditions, remains unresolved. Parvalbumin-positive interneurons (PV-INs) regulate hippocampal excitation-inhibition balance and are directly modulated by dopamine (DA). These neurons are protected by perineuronal nets (PNNs), extracellular-matrix structures supporting fast GABAergic signaling and neuronal resilience. We tested whether midbrain-derived DA loss is sufficient to destabilize hippocampal PV-IN function, potentially promoting their vulnerability or affecting PNN integrity. Through stereotaxic unilateral 6-hydroxy-dopamine lesion of the Ventral Tegmental Area/Substantia Nigra pars compacta in C57BL/6 N mice, we reduced the hippocampal DA tone and midbrain-derived synaptic input onto PV-INs. At 1-month post-lesion, PV-IN numbers were preserved, but the PNN integrity was reduced, accompanied by increased expression of tissue plasminogen activator (tPA), a PNN-remodeling protease. In CA1 pyramidal neurons, spontaneous inhibitory postsynaptic currents showed reduced frequency with faster decay, and bicuculline unmasked heightened population-spike excitability. By 6-months post-lesion, PV-IN numbers declined significantly, especially in CA1, demonstrating progressive vulnerability. D2/D3 receptor (D2/D3R) activation with quinpirole normalized tPA levels in PV-INs ex vivo, restored PNN integrity after sub-chronic treatment in vivo and increased inhibitory postsynaptic-event frequency, indicating functional recovery of GABAergic drive. These findings support the involvement of a DA-D2/D3R-tPA axis contributing to PV-IN extracellular-matrix integrity and hippocampal inhibitory tone. They also demonstrate that DA depletion is sufficient to trigger PNN breakdown, reduce GABAergic inhibition, network hyperexcitability, and cause progressive PV-IN loss independently of canonical protein aggregates like Aβ, tau or α-synuclein, characteristic of AD, DLB or AD-PD. This mechanism links midbrain degeneration to hippocampal circuit failure, highlighting D2/D3R signaling and extracellular proteolysis as actionable targets for early circuit stabilization across AD, DLB, and AD-PD.
Insights
Midbrain dopamine loss destabilizes hippocampal circuits by degrading perineuronal nets, leading to progressive neuron loss. Restoring dopamine D2/D3 receptor signaling protects these nets and circuit function in neurodegenerative diseases.
Area of Science:
- Neuroscience
- Cell Biology
- Neurodegenerative Diseases
Background:
- Midbrain dopaminergic degeneration is an early feature of Alzheimer's Disease (AD), dementia with Lewy bodies (DLB), and AD-Parkinson's disease overlap (AD-PD).
- Parvalbumin-positive interneurons (PV-INs) are crucial for hippocampal excitation-inhibition balance and are modulated by dopamine (DA).
- Perineuronal nets (PNNs) protect PV-INs, supporting GABAergic signaling and neuronal resilience.
Purpose of the Study:
- To investigate if midbrain-derived DA loss is sufficient to destabilize hippocampal PV-IN function and PNN integrity.
- To explore the role of the DA-D2/D3R-tPA axis in maintaining PV-IN extracellular-matrix integrity.
- To identify potential therapeutic targets for stabilizing hippocampal circuits in AD, DLB, and AD-PD.
Main Methods:
- Stereotaxic unilateral 6-hydroxy-dopamine lesion of the Ventral Tegmental Area/Substantia Nigra pars compacta in mice to reduce hippocampal DA tone.
- Assessment of PV-IN numbers, PNN integrity, and tissue plasminogen activator (tPA) expression at 1 and 6 months post-lesion.
- Electrophysiological recordings of inhibitory postsynaptic currents and neuronal excitability in CA1 pyramidal neurons.
- Pharmacological interventions using D2/D3 receptor (D2/D3R) agonist quinpirole.
Main Results:
- DA depletion led to reduced PNN integrity and increased tPA expression by 1 month, without altering PV-IN numbers.
- CA1 pyramidal neurons exhibited reduced inhibitory postsynaptic current frequency and faster decay, with heightened excitability.
- By 6 months, a significant decline in PV-IN numbers was observed, particularly in CA1.
- D2/D3R activation normalized tPA levels, restored PNN integrity, and increased inhibitory postsynaptic event frequency, indicating functional recovery.
Conclusions:
- Midbrain DA depletion is sufficient to destabilize hippocampal PV-INs, disrupt PNN integrity, reduce GABAergic inhibition, and cause progressive PV-IN loss.
- A DA-D2/D3R-tPA axis is involved in maintaining PV-IN extracellular-matrix integrity and hippocampal inhibitory tone.
- This mechanism links midbrain degeneration to hippocampal circuit failure, independent of canonical AD pathologies.
- D2/D3R signaling and extracellular proteolysis represent actionable targets for early circuit stabilization in AD, DLB, and AD-PD.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction

